SourcingLink.net, Inc./ US8361714053 /
- - | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
-USD | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | - | - |
GlobeNewswire
2021-03-31
Oncology Pharma Has Provided Initial Funding to NanoSmart Pharmaceuticals to Conduct Feasibility Stu...
GlobeNewswire
2021-03-10
Oncology Pharma, Inc. Vetting CROs to Develop Research Plan and Indications for Recently Licensed Ca...
GlobeNewswire
2021-02-26
Oncology Pharma Signs Worldwide Licensing Agreement with Sybleu, Inc. for Commercialization of Chemo...
GlobeNewswire
2021-02-22
Oncology Pharma Extends Licensing Agreement with NanoSmart Pharmaceuticals, Inc. for Veterinary Onco...
GlobeNewswire
2021-02-16
Oncology Pharma is Pleased to Welcome New Chairman to Its Scientific Advisory Board
GlobeNewswire
2021-02-09
Oncology Pharma Renews Licensing Agreement With Ribera Solutions LLC for Its Connect2Med Clinical Tr...
GlobeNewswire
2021-02-03
Oncology Pharma Extends Its Licensing Agreement with NanoSmart Pharmaceuticals, Inc. for Human Oncol...
GlobeNewswire
2020-08-27
Oncology Pharma Announces Extension of Letter of Intent with Kalos Therapeutics, Retained an Interim...
GlobeNewswire
2020-04-06
Oncology Pharma and Kalos Therapeutics Expand Licensing Agreement for Exploring Kalos's Anti-Cancer ...
GlobeNewswire
2019-12-27
CORRECTION: Oncology Pharma Receives LOI for Financing for US$ 38.4M from SCP Investment Partners, L...
GlobeNewswire
2019-12-23
Oncology Pharma Receives LOI for Financing for US$ 38.4M from SCP Partners Ltd
GlobeNewswire
2019-12-12
Oncology Pharma Signs Letter of Intent to Acquire a Significant Stake in Diagnomics, Inc.
GlobeNewswire
2019-11-06
Oncology Pharma and Ribera Solutions Signed a Licensing Agreement for the Use of Ribera's Clinical T...
GlobeNewswire
2019-10-15
Oncology Pharma Appoints Dr. Vijay Mahant as the Chief Scientific Officer and Chief Operating Office...
GlobeNewswire
2019-10-08
Oncology Pharma Elects Dr. Stefan Gruenwald (MD, PhD) to its Board of Directors
GlobeNewswire
2019-09-30
Kalos Therapeutics, Inc., Oncology Pharmaceuticals and NanoSmart Pharmaceuticals, Inc., Combination ...
GlobeNewswire
2019-08-19
Update: Oncology Pharma Signed a Letter of Intent with Kalos Therapeutics for an Exclusive World-Wi...
GlobeNewswire
2019-07-15
Oncology Pharma Appoints Stefan Gruenwald (MD. Ph.D) as an Advisor on its Advisory Board